Chapter 1
Chapter 1 – Burden: mortality, morbidity and risk factors 10 cerebrovascular disease (3). These important behavioural risk factors of heart disease and stroke are
Download Chapter 1
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Good, Practices, Pharmaceutical, Good distribution practices for, Distribution
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating
Related documents
the diabetes epidemic and its impact on Europe - …
www.oecd.org7 the burden of chronic diseases Chronic diseases are one of the greatest challenges for Europe. the most common of these diseases are cardiovascular disease (heart disease and stroke), cancer,
Health at a Glance 2017: OECD Indicators
www.oecd.orgHEALTH AT A GLANCE 2017: OECD INDICATORS © OECD 2017 More via www.oecd.org/health/health-at-a-glance.htm Health at a Glance 2017: OECD Indicators
Code, 2017, Indicator, Glance, A glance 2017, Oecd indicators
Noncommunicable diseases (brochure) - …
www.euro.who.intPAGE 3 “Today’s main burdens are chronic noncommunicable diseases, both physical and mental, injuries and violence, and disability.” Zsuzsanna jakab, who regional director for europe
Disease, Chronic, Europe, Noncommunicable, Noncommunicable diseases, Chronic noncommunicable diseases
Addressing Alcohol Misuse in Wales
www.wales.nhs.ukSmoking is the largest single preventable cause of ill health and death in Wales Smoking causes Adults who smoke Young people (11-16 yrs) who smoke Smoking in Wales 1 in 5 adults smoke RIP 18% adult deaths
ENCOURAGING PEOPLE TO STOP SMOKING - WHO
www.who.intwho/msd/mdp/01.4 original: english distr.: general behavioural science learning modules encouraging people to stop smoking department of mental health
People, Post, Encouraging, Smoking, Encouraging people to stop smoking